It is hard to imagine they are talking about anyone else. This is going to be a done deal at some point. It really explanes the unwavering confidence by CYDY mgmt and the easy access to funds, not to mention the non-disclosure agreements signed by mgmt precluding them to buy stock due to insider information. I think they know what they need to do and that it will happen. the only question is at what level of data is enough and how much cydy can command. primary endpoint in p3 combo? p3 combo + the 100 safety in mono? primary endpoint in mono? or FDA p3 approval for combo? I don't know when or how much but we will get there.
Market Data 
Markets 
AI
